Endothelial NO synthase genotype and risk of preeclampsia: A multicenter case-control study

Hypertension

Volumn 44, Issue 5, 2004, Pages 702-707

  Serrano, Norma C ^a,i   Casas, Juan P ^b   Díaz, Luis A ^a   Páez, Carolina ^a   Mesa, Clara M ^b   Cifuentes, Rodrigo ^c   Monterrosa, Alvaro ^d   Bautista, Alejandro ^e   Hawe, Emma ^f   Hingorani, Aroon D ^b   Vallance, Patrick ^b   López Jaramillo, Patricio ^g,h  

^a UNIVERSIDAD AUTÓNOMA DE BUCARAMANGA   (Colombia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Instituto de Ciencias de la Salud   (Colombia)

^d UNIVERSIDAD DEL VALLE   (Colombia)

^e UNIVERSIDAD DE CARTAGENA   (Colombia)

^f UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^g Inst Colombiano de Invest Biomed   (Colombia)

^h Fund Cardiovasc Oriente Colombiano ^*  (Colombia)

ⁱ Univ Auton Bucaramanga Colombia   (Colombia)

Author keywords

Case control studies; Haplotypes; Nitric oxide synthase; Polymorphism; Preeclampsia

Indexed keywords

ASPARTIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMIC ACID;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; INCIDENCE; INHERITANCE; INTRON; MULTIVARIATE ANALYSIS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RISK;

ADULT; CASE-CONTROL STUDIES; COLOMBIA; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 7244236383     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000143483.66701.ec     Document Type: Article

References (42)

1. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol. 1988;158:80-83.
2. Lopez-Jaramillo P, Casas JP, Serrano N. Preeclampsia: from epidemiological observations to molecular mechanisms. Braz J Med Biol Res. 2001;10:1227-1235.
3. Williams DJ, Vallance PJT, Neild GH, Spencer JA, Imms FJ. Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol. 1997; 272:H748-H752.
4. Weiner CP, Knowles RG, Moncada S. Induction of nitric oxide synthases early in pregnancy. Am J Obstet Gynecol. 1994;171:838-843.
5. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1998;256:H1060-H1065.
6. Halligan A, O'Brien E, O'Malley K, Mee F, Atkins N, Conroy R, Walshe JJ, Darling M. Twenty-four-hour ambulatory blood pressure measurement in a premigravid popultion. J Hypertens. 1993;11:869-873.
7. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
8. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
9. Hingorani AD. Endothelial nitric oxide synthase polymorphisms and hypertension. Curr Hypertens Rep. 2003;5:19-25.
10. Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res. 1999;43:562-571.
11. Arngrimsson R, Hayward C, Nadaud S, Baldursdottir A, Walker JJ, Liston WA, Bjarnadottir RI, Brock DJ, Geirsson RT, Connor JM, Soubrier F. Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet. 1997;61:354-362.
12. Yoshimura T, Yoshimura M, Tabata A, Shimasaki Y, Nakayama M, Miyamoto Y, Saito Y, Nakao K, Yasue H, Okamura H. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Investig. 2000;7:238-241.
13. Kobashi G, Yamada H, Ohta K, Kato E, Ebina Y, Fujimoto S. Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy. Am J Med Genet. 2001;103:241-244.
14. Hakli T, Romppanen EL, Hiltunen M, Helisalmi S, Punnonen K, Heinonen S. Endothelial nitric oxide synthase polymorphism in preeclampsia. J Soc Gynecol Investig. 2003;10:154-157.
15. Bashford MT, Hefler LA, Vertrees TW, Roa BB, Gregg AR. Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia. Am J Obstet Gynecol. 2001;184:1345-1350.
16. Tempfer CB, Dorman K, Deter RL, O'Brien WE, Gregg AR. An endothelial nitric oxide synthase gene polymorphism is associated with preeclampsia. Hypertens Pregnancy. 2001;20:107-118.
17. Pickering TG, Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc. Am J Hypertens. 1996;9:1-11.
18. Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program. Am J Obstet Gynecol. 2000;183:S1-S22.
19. 298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation. 1999;100:1515-1520.
20. Tanus-Santos JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics. 2001;11:719-725.
21. Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HH. Nonuniform recombination within the human beta-globin gene cluster. Am J Hum Genet. 1984;36:1239-1258.
22. Casas JP, Bautista LE, Humphries SE, Hingorani AD. Endothelial nitric oxide synthase genotype and ischemic heart disease: meta-analysis of 26 studies involving 23028 subjects. Circulation. 2004;109:1359-1365.
23. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79:340-349.
24. Hosmer DW, Taber S, Lemeshaw S. The importance of assessing the fit of logistic regression models: a case study. Am J Public Health. 1991;81: 1630-1635.
25. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet. 2004;68:165-177.
26. Lopez-Jaramillo P, Narvaez M, Calle A, Rivera J, Jacome P, Ruano C, Nava E. Cyclic guanosine 3′,5′monophosphate concentrations in preeclampsia: effects of hydralazine. Br J Obstet Gynaecol. 1996;103:33-38.
27. Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet. 2003;361:1511-1517.
28. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. J Am Med Assoc. 2001;285:1607-1612.
29. Smith GCS, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births. Lancet. 2001;357:2002-2006.
30. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A. 2000;6:2832-2835.
31. Persu A, Stoenoiu MS, Messiaen T, Davila S, Robino C, El-Khattabi O, Mourad M, Horie S, Feron O, Balligand JL, Wattiez R, Pirson Y, Chauveau D, Lens XM, Devuyst O. Modifier effect of eNOS in autosomal dominant polycystic kidney disease. Hum Mol Genet. 2002; 11:229-241.
32. Fairchild TA, Fulton D, Fontana JT, Gratton JP, McCabe TJ, Sessa WC. Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)→Asp variant of human endothelial nitric-oxide synthase. J Biol Chem. 2001; 276:26674-26679.
33. Savvidou MD, Vallance PJ, Nicolaides KH, Hingorani AD. Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension. 2001;38:1289-1293.
34. Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol. 1997;17: 3147-3153.
35. Jeerooburkhan N, Jones LC, Bujac S, Cooper JA, Miller GJ, Vallance P, Humphries SE, Hingorani AD. Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease. Hypertension. 2001;38:1054-1061.
36. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K. T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99:2864-2870.
37. Miyamoto Y, Saito Y, Nakayama M, Shimasaki Y, Yoshimura T, Yoshimura M, Harada M, Kajiyama N, Kishimoto I, Kuwahara K, Hino J, Ogawa E, Hamanaka I, Kamitani S, Takahashi N, Kawakami R, Kangawa K, Yasue H, Nakao K. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T→C mutation associated with coronary spastic angina. Hum Mol Genet. 2000;9:2629-2637.
38. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet. 2003;361:598-604.
39. Wacholder S, Rothman N, Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst. 2000;92:1151-1158.
40. Wang Y, Localio R, Rebbeck TR. Evaluating bias due to population stratification in case-control association studies of admixed populations. Genet Epidemiol. 2004;27:14-20.
41. Smith GD, Ebrahim S. Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol. 2004;33:30-42.
42. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet. 2003;361:865-872.